Archive: Archive: 2019

Premium

The First Stage Investor Cannabis Portfolio Is Here

By Adam Sharp on November 12, 2019

The First Stage Investor cannabis portfolio is here! Here’s how you should view the cannabis market and which companies you need to invest in.
Premium
In Part 3 of our Startup Insider interview with NowRx, we take a deep dive into the founders’ strategy.

Veterans Are Ready for Medical Marijuana

By Allison Brickell on November 11, 2019

A recent survey shows a huge number of veterans are interested in medical marijuana as a treatment option. Which means the current U.S. Department of Veterans Affairs marijuana policy needs a major update.
In this week’s Mailbag, the Early Investing team addresses startup funding rounds and whether Uber and Lyft are good buys.
In the news this week: New York hemp farmers get a break, Saudi Arabia backs Travis Kalanick again and David Marcus says bitcoin isn’t a currency.

Cannabis Isn’t Going Anywhere

By Adam Sharp on November 8, 2019

Cannabis stocks are down, but this industry is still booming. If you can ride out the bear market and buy the dip, you’ll be sitting pretty long term.
Summary Gold and bitcoin have had an interesting year. Bitcoin has outperformed gold in six out of the 10 months so far this year. Adam Sharp explains why it’s important to have both assets in your portfolio… and exactly how each should fit into your portfolio allocation… While bitcoin…

Startup Insider: How NowRx Works With Google Home

By Early Investing on November 7, 2019

In Part 2 of our interview with NowRx, we go behind the scenes to see how the company tracks orders, maps out delivery routes and more.

The Deep, Dark Hole of Drug Addiction

By Andy Gordon on November 6, 2019

The opioid crisis has taken thousands of lives. And Andy Gordon has experienced the damage firsthand. But there is hope for a better future.
Premium

Investing Outside of the Bay Area

By Adam Sharp on November 5, 2019

The Bay Area is losing its edge. Here’s where else you can find good startup deals.
Premium

Recommendation: Reinvest in NowRx

By Early Investing on November 4, 2019

Today’s Startup Insider video features the founders of NowRx, a startup that’s disrupting the brick-and-mortar pharmacy industry. In Part 1 of this interview, they discuss what they do, what inspired them to start the company and more.

Cannabis Companies Spend Record Amount on Lobbying

By Allison Brickell on November 4, 2019

Cannabis companies have spent a record amount on lobbying this year. Here’s why.
In this week’s Mailbag, the Early Investing team explains why altcoins are underperforming and how today’s startup deal flow is better than ever.

News Fix: Who Watches the Watchers?

By Vin Narayanan on November 2, 2019

In the news this week: Colleges become legal battlegrounds for cannabis, China praises blockchain and the Fix ponders who watches the watchers.

Buy Pot Stocks While Prices Are Low

By Adam Sharp on November 1, 2019

Marijuana stocks have taken a big hit across the board. That means they’re a great buying opportunity.
Premium

Preparing for Modern Monetary Theory

By Adam Sharp on November 1, 2019

It seems more and more likely that the Federal Reserve will begin printing money as a way to pay off the national debt. So it’s important to have exposure to certain alternative investments.